Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Stomach Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Carcinoma, Hepatocellular 5Recurrence 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Thyroid Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Glioma 3Glioblastoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Osteosarcoma 2Mouth Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

lenvatinib 2Gemcitabine 2Floxuridine 2Drug Therapy 2durvalumab 1apatinib 1Surgical Procedures, Operative 1Oxaliplatin 1Dexamethasone 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cirrhosis, Familial, with Pulmonary Hypertension × Surgical Procedures, Operative × Clear all
NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
70 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡